M6P Therapeutics is developing the next-generation enzyme replacement and gene therapies for lysosomal storage disorders. We have discovered a novel method for significantly increasing mannose-6-phosphate phosphorylation of various lysosomal enzymes. This allows for markedly improved enzyme delivery to target tissues and promises improved clinical outcomes.
Location: United States, Missouri, Saint Louis
Member count: 11-50
Founded date: 2017
Investors 1
| Date | Name | Website |
| - | 6 Dimensio... | 6dimension... |
Mentions in press and media 1
| Date | Title | Description | Category | Author | Source |
| 25.06.2021 | Roth Capit... | NEWPORT BEACH, Calif., June 25... | - | - | marketscre... |